Search Results - Sigrun Halvorsen

Refine Results
  1. 1
    The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription

    The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription by Sean van Diepen, Sigrun Halvorsen, Venu Menon

    Published 2024
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  2. 2
    Remnant cholesterol, plasma triglycerides and risk of cardiovascular disease events in young adults: a prospective cohort study

    Remnant cholesterol, plasma triglycerides and risk of cardiovascular disease events in young adults: a prospective cohort study by Eirik Aaseth, Sigrun Halvorsen, Ragnhild Helseth, Jørgen Gravning

    Published 2025
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Survival after myocardial infarction according to left ventricular function and heart failure symptoms

    Survival after myocardial infarction according to left ventricular function and heart failure symptoms by Jarle Jortveit, Peder L. Myhre, Kristian Berge, Sigrun Halvorsen

    Published 2025
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances

    Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances by Ellen Bøhmer, Pavel Hoffmann, Michael Abdelnoor, Harald Arnesen, Sigrun Halvorsen

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction

    Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction by Sigrun Halvorsen, Jarle Jortveit, Pål Hasvold, Marcus Thuresson, Erik Øie

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

    Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study by Ole-Christian Walter Rutherford, Christian Jonasson, Waleed Ghanima, Fabian Söderdahl, Sigrun Halvorsen

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation

    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation by Ole-Christian Walter Rutherford, Christian Jonasson, Waleed Ghanima, Fabian Söderdahl, Sigrun Halvorsen

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-2020

    Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-2020 by Ingrid Engebretsen, Francisco Oteiza, Elisabeth Floberghagen Birkelund, Stephanie Brandal, Christoffer Bugge, Sigrun Halvorsen

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease

    Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease by Jarle Jortveit, Sigrun Halvorsen, Anete Kaldal, Are Hugo Pripp, Ragna Elise Støre Govatsmark, Jørund Langørgen

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    IL-6 signalling in patients with acute ST-elevation myocardial infarction

    IL-6 signalling in patients with acute ST-elevation myocardial infarction by Vibeke Ritschel, Ingebjørg Seljeflot, Harald Arnesen, Sigrun Halvorsen, Thomas S. Weiß, Jan Eritsland, Geir Øystein Andersen

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

    A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants by Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, Pål Falck, Oddvar Solli, Christian Jonasson

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

    Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction by Vibeke Ritschel, Ingebjørg Seljeflot, Harald Arnesen, Sigrun Halvorsen, Jan Eritsland, Morten Wang Fagerland, Geir Øystein Andersen

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study

    Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study by Tonje R. Johannessen, Sven Eirik Ruud, Anne Cecilie K. Larstorp, Dan Atar, Sigrun Halvorsen, Beate Nilsen, Odd Martin Vallersnes

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients

    Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients by Gemma Chiva‐Blanch, Vibeke Bratseth, Vibeke Ritschel, Geir Øystein Andersen, Sigrun Halvorsen, Jan Eritsland, Harald Arnesen, Lina Badimón, Ingebjørg Seljeflot

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups

    Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups by Georg Gelbenegger, Marek Postuła, Ladislav Pecen, Sigrun Halvorsen, Maciej Lesiak, Christian Schoergenhofer, Bernd Jilma, Christian Hengstenberg, Jolanta M. Siller‐Matula

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Aspirin Therapy in Primary Cardiovascular Disease Prevention

    Aspirin Therapy in Primary Cardiovascular Disease Prevention by Sigrun Halvorsen, Felicita Andreotti, Jurriën M. ten Berg, Marco Cattaneo, S Coccheri, Roberto Marchioli, João Morais, Freek W.A. Verheugt, Raffaele De Caterina

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis

    Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis by Carlo Patrono, João Morais, Colin Baigent, Jean‐Philippe Collet, Desmond J. Fitzgerald, Sigrun Halvorsen, Bianca Rocca, Agneta Siegbahn, Robert F. Storey, Gemma Vilahur

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery

    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC)... by Florian Schlotter, Kurt Huber, Christian Hassager, Sigrun Halvorsen, Pascal Vranckx, Janine Pöss, Konstantin A. Krychtiuk, Roberto Lorusso, Nikolaos Bonaros, Patrick A. Calvert, Matteo Montorfano, Hölger Thiele

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial

    The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial by Roopinder K. Sandhu, Justin A. Ezekowitz, Ulrika Andersson, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael Hanna, Ziad Hijazi, Petr Janský, Renato D. Lópes, Lars Wallentin

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases

    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC coun... by Sofie Gevaert, Sigrun Halvorsen, Peter Sinnaeve, Antonia Sambola, Geeta Gulati, Patrizio Lancellotti, Peter van der Meer, Alexander R. Lyon, Dimitrios Farmakis, Geraldine Lee, Giuseppe Boriani, Ashutosh Wechalekar, Alicia Okines, Riccardo Asteggiano

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: